Free Trial

USANA Health Sciences (USNA) 10K Form and Latest SEC Filings 2026

USANA Health Sciences logo
$19.19 +0.63 (+3.38%)
Closing price 03:59 PM Eastern
Extended Trading
$19.79 +0.60 (+3.14%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest USANA Health Sciences SEC Filings & Recent Activity

USANA Health Sciences (NYSE:USNA) has submitted 738+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 5, 2026.

Form 4
USANA HEALTH SCIENCES INC Reports Ownership Change on Apr. 27, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
USANA Health Sciences Files Current Report on May. 5, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
USANA Health Sciences Files Annual Report on Mar. 16, 2026

The 10-K contains USANA Health Sciences's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

USANA Health Sciences SEC Filing History

Browse USANA Health Sciences' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/05/2026 3:17 PM
USANA Health Sciences (896264) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2026 11:33 AM
Ding Xia (1889687) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 11:34 AM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 11:36 AM
Pelosi Peggie (1763161) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 11:37 AM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2026 3:50 PM
USANA Health Sciences (896264) Filer
Form DEF 14A
04/07/2026 3:53 PM
USANA Health Sciences (896264) Filer
Form ARS
03/30/2026 8:20 PM
USANA Health Sciences (896264) Subject
WENTZ MYRON W (1203301) Filed by
Form SCHEDULE 13D/A
03/27/2026 12:51 PM
USANA Health Sciences (896264) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/20/2026 3:53 PM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 1:57 PM
USANA Health Sciences (896264) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2026 5:08 PM
Benedict Peter (2032126) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 11:00 AM
Guest Kevin (1353496) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 11:01 AM
Foukas Joshua (1748208) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 11:03 AM
IIEKKING G DOUG (1203346) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 11:04 AM
Jones Paul A. (1565541) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 11:05 AM
Neidig Brent (1775522) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 11:18 AM
Noot Walter (1691991) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 10:58 AM
Armstrong Kathryn Michelle (2053876) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 10:59 AM
Benedict Peter (2032126) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 6:03 PM
Armstrong Kathryn Michelle (2053876) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 6:06 PM
Benedict Peter (2032126) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 6:12 PM
Foukas Joshua (1748208) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 5:26 PM
Neidig Brent (1775522) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 5:28 PM
Noot Walter (1691991) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 5:17 PM
Guest Kevin (1353496) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 5:18 PM
IIEKKING G DOUG (1203346) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 5:22 PM
Jones Paul A. (1565541) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 5:52 PM
Jones Paul A. (1565541) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 5:54 PM
Neidig Brent (1775522) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 5:55 PM
Noot Walter (1691991) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 5:56 PM
Benedict Peter (2032126) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 5:50 PM
Foukas Joshua (1748208) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 5:51 PM
IIEKKING G DOUG (1203346) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 5:48 PM
Guest Kevin (1353496) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 2:29 PM
Nixon J Scott (1709352) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 2:30 PM
USANA Health Sciences (896264) Issuer
Winssinger Frederic J (1673356) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 2:32 PM
USANA Health Sciences (896264) Issuer
WOOD TIMOTHY E (1261778) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 2:20 PM
Ding Xia (1889687) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 2:21 PM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 2:25 PM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 2:26 PM
Pelosi Peggie (1763161) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2026 12:21 PM
DIMENSIONAL FUND ADVISORS LP (354204) Filed by
USANA Health Sciences (896264) Subject
Form SCHEDULE 13G/A
01/21/2026 11:30 AM
BlackRock, Inc. (2012383) Filed by
USANA Health Sciences (896264) Subject
Form SCHEDULE 13G/A
01/12/2026 5:29 AM
USANA Health Sciences (896264) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2026 8:01 AM
USANA Health Sciences (896264) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 10:21 AM
Benedict Peter (2032126) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 10:25 AM
Mulham David Mulham (1697433) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 4:03 PM
Benedict Peter (2032126) Reporting
USANA Health Sciences (896264) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/10/2025 4:20 PM
USANA Health Sciences (896264) Issuer
Winssinger Frederic J (1673356) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2025 4:11 PM
USANA Health Sciences (896264) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2025 10:28 AM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2025 10:30 AM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 4:16 PM
USANA Health Sciences (896264) Issuer
Winssinger Frederic J (1673356) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 4:18 PM
USANA Health Sciences (896264) Issuer
WOOD TIMOTHY E (1261778) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 4:24 PM
Pelosi Peggie (1763161) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 4:04 PM
Ding Xia (1889687) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 4:07 PM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 4:09 PM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 4:12 PM
Nixon J Scott (1709352) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 3:12 PM
USANA Health Sciences (896264) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/14/2025 3:50 PM
PZENA INVESTMENT MANAGEMENT LLC (1027796) Filed by
USANA Health Sciences (896264) Subject
Form SCHEDULE 13G/A
10/09/2025 12:48 PM
DIMENSIONAL FUND ADVISORS LP (354204) Filed by
USANA Health Sciences (896264) Subject
Form SCHEDULE 13G
08/08/2025 1:22 PM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025 3:50 PM
USANA Health Sciences (896264) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2025 10:03 AM
Mulham David Mulham (1697433) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2025 1:50 PM
USANA Health Sciences (896264) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
07/28/2025 12:00 PM
Pelosi Peggie (1763161) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 12:04 PM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 12:08 PM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 12:11 PM
Ding Xia (1889687) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 12:15 PM
Brown Jim (1555707) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 12:18 PM
Benedict Peter (2032126) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 12:22 PM
Armstrong Kathryn Michelle (2053876) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 11:45 AM
USANA Health Sciences (896264) Issuer
WOOD TIMOTHY E (1261778) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 11:48 AM
USANA Health Sciences (896264) Issuer
Winssinger Frederic J (1673356) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 11:54 AM
Nixon J Scott (1709352) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025 10:54 AM
USANA Health Sciences (896264) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025 1:47 PM
USANA Health Sciences (896264) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/10/2025 11:35 AM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025 4:36 PM
Noot Walter (1691991) Reporting
USANA Health Sciences (896264) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025 1:31 PM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 1:33 PM
USANA Health Sciences (896264) Issuer
Winssinger Frederic J (1673356) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 1:34 PM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 1:35 PM
Nixon J Scott (1709352) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 1:37 PM
Pelosi Peggie (1763161) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 1:39 PM
USANA Health Sciences (896264) Issuer
WOOD TIMOTHY E (1261778) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 1:40 PM
Ding Xia (1889687) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025 9:42 AM
IIEKKING G DOUG (1203346) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025 2:34 PM
FULLER GILBERT A (1203302) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025 2:43 PM
Gull Global Ltd (1636301) Reporting
USANA Health Sciences (896264) Issuer
WENTZ MYRON W (1203301) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025 2:27 PM
Ding Xia (1889687) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025 2:30 PM
Fleming John Turman (1824992) Reporting
USANA Health Sciences (896264) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025 1:42 PM
USANA Health Sciences (896264) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

USANA Health Sciences SEC Filings - Frequently Asked Questions

USANA Health Sciences (USNA) has submitted 738+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

USANA Health Sciences's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 8-K submitted on May 5, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:USNA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners